Royal Bank of Canada
SKBI

Royal Bank of Canada’s SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) SKBI Stock Holding History

Royal Bank of Canada’s Portfolio SKBI Stock Details SKBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-30,573
Closed -$81K – 6973
2015
Q2 		$81K Sell
30,573
-361
-1% -$1.24K ﹤0.01% 4947
2015
Q1 		$121K Sell
30,934
-918
-3% -$3.89K ﹤0.01% 4517
2014
Q4 		$134K Sell
31,852
-3,870
-11% -$16.7K ﹤0.01% 4590
2014
Q3 		$150K Buy
35,722
+399
+1% +$2.17K ﹤0.01% 4384
2014
Q2 		$259K Sell
35,323
-68
-0.2% -$406 ﹤0.01% 3982
2014
Q1 		$232K Sell
35,391
-81
-0.2% -$410 ﹤0.01% 3990
2013
Q4 		$125K Sell
35,472
-8,169
-19% -$36K ﹤0.01% 4459
2013
Q3 		$254K Buy
+43,641
New +$108K ﹤0.01% 3912

Other funds holding SKBI

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada's SKBI Position: Q3 2015 in Review

Royal Bank of Canada sold out of SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) in Q3 2015, closing a stake of 30,573 shares — an estimated $81K sold.

Royal Bank of Canada first reported a position in SKBI in Q3 2013 and held it in 8 quarters. The position peaked at $259K in Q2 2014. 10 funds tracked by Wall St. Rank hold SKBI as of Q3 2015.

  • Royal Bank of Canada reported no remaining SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position as of Q3 2015 after selling out during the quarter.
  • Royal Bank of Canada sold 30,573 SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) shares in Q3 2015, an estimated $81K.
  • Royal Bank of Canada first reported a position in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) in Q3 2013 and held it in 8 quarters.
  • Royal Bank of Canada's SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position peaked at $259K in Q2 2014.
  • 10 funds tracked by Wall St. Rank held SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) as of Q3 2015.

Based on Royal Bank of Canada's 13F filing for Q3 2015, filed 16 Nov 2015.